top of page
Co-administration of treatment for rifampicin-resistant TB and chronic HCV infection: A TBnet and ESGMYC study.
Co-administration of treatment for rifampicin-resistant TB and chronic HCV infection: A TBnet and ESGMYC study.
2022
J Infect
Tunesi S, Dû DL, Gualano G, et al.
DIO:
10.1016/j.jinf.2022.03.004
bottom of page